Literature DB >> 6037525

EEG and behavioral comparison of the effects of gamma-hydroxybutyrate, gamma-butyrolactone and short chain fatty acids in the rat.

R J Marcus, W D Winters, K Mori, C E Spooner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6037525     DOI： 10.1016/0028-3908(67)90003-2

Source DB:  PubMed          Journal:  Int J Neuropharmacol        ISSN： 0375-9458


× No keyword cloud information.
  6 in total

1.  Sodium oxybate: a potential new pharmacological option for the treatment of fibromyalgia syndrome.

Authors:  Todd J Swick
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-08       Impact factor: 5.346

Review 2.  Biochemical dissection of the gamma-aminobutyrate synapse.

Authors:  A J Turner; S R Whittle
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

Review 3.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  The effect of gamma-butyrolactone on locomotor activity in the rat.

Authors:  J A Davies
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

5.  Effects of gamma-hydroxybutyrate on chick behaviour, electrocortical activity and crossed extensor reflexes.

Authors:  G Osuide
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

Review 6.  A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures.

Authors:  Marcello Venzi; Giuseppe Di Giovanni; Vincenzo Crunelli
Journal:  CNS Neurosci Ther       Date:  2014-11-18       Impact factor: 5.243
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.